117 related articles for article (PubMed ID: 10809347)
1. Response of complicated methicillin-resistant Staphylococcus aureus endocarditis to the addition of trovafloxacin.
Eckart RE; Hospenthal DR; Fishbain JT
Pharmacotherapy; 2000 May; 20(5):589-92. PubMed ID: 10809347
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.
Kim YS; Liu Q; Chow LL; Chambers HF; Täuber MG
Antimicrob Agents Chemother; 1998 Dec; 42(12):3325-7. PubMed ID: 9835540
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1999 Jan; 43(1):77-84. PubMed ID: 9869569
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Aeschlimann JR; Houlihan HH; Mercier RC; Rybak MJ
Antimicrob Agents Chemother; 1998 Feb; 42(2):254-6. PubMed ID: 9527768
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.
Bayer AS; Li C; Ing M
Antimicrob Agents Chemother; 1998 Jul; 42(7):1837-41. PubMed ID: 9661030
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin.
Bonilla HF; Zarins LT; Bradley SF; Kauffman CA
Diagn Microbiol Infect Dis; 1996 Sep; 26(1):17-21. PubMed ID: 8950524
[TBL] [Abstract][Full Text] [Related]
7. Oral temafloxacin versus vancomycin for therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Hessen MT; Pitsakis PG; Kaye D
Antimicrob Agents Chemother; 1990 Jun; 34(6):1143-5. PubMed ID: 2393273
[TBL] [Abstract][Full Text] [Related]
8. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
9. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
[TBL] [Abstract][Full Text] [Related]
10. Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis.
Gilbert M; Boscia JA; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1986 Mar; 29(3):461-3. PubMed ID: 3459391
[TBL] [Abstract][Full Text] [Related]
11. Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Maserati R; Cagni AE; Segú C
Chemotherapy; 1996; 42(2):133-9. PubMed ID: 8697888
[TBL] [Abstract][Full Text] [Related]
12. CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
Kaatz GW; Seo SM; Lamp KC; Bailey EM; Rybak MJ
Antimicrob Agents Chemother; 1992 Jun; 36(6):1192-7. PubMed ID: 1329613
[TBL] [Abstract][Full Text] [Related]
13. Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis.
Piper KE; Rouse MS; Ronningen KL; Steckelberg JM; Wilson WR; Patel R
Antimicrob Agents Chemother; 2000 Sep; 44(9):2554-6. PubMed ID: 10952616
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
Bassetti M; Di Biagio A; Del Bono V; Cenderello G; Bassetti D
Int J Antimicrob Agents; 2004 Jul; 24(1):83-4. PubMed ID: 15225867
[TBL] [Abstract][Full Text] [Related]
15. Sitafloxacin (DU-6859a) and trovafloxacin: postantibiotic effect and in vitro interactions with rifampin on methicillin-resistant Staphylococcus aureus.
Giamarellou-Bourboulis EJ; Sambatakou H; Grecka P; Chryssouli Z; Giamarellou H
Diagn Microbiol Infect Dis; 1999 Aug; 34(4):301-7. PubMed ID: 10459481
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy.
Karchmer AW
Am J Med; 1985 Jun; 78(6B):116-27. PubMed ID: 3893113
[TBL] [Abstract][Full Text] [Related]
17. [Resistance and new antibiotic strategies. New antistaphylococcal antibiotics].
Bergogne-Bérézin E
Presse Med; 2000 Dec; 29(37):2023-7. PubMed ID: 11155724
[TBL] [Abstract][Full Text] [Related]
18. A successful salvage therapy with daptomycin and linezolid for right-sided infective endocarditis and septic pulmonary embolism caused by methicillin-resistant Staphylococcus aureus.
Yazaki M; Oami T; Nakanishi K; Hase R; Watanabe H
J Infect Chemother; 2018 Oct; 24(10):845-848. PubMed ID: 29534850
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
Bayer AS; Lam K
J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
[TBL] [Abstract][Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job's syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin.
Cunha BA; Krol V; Kodali V
Heart Lung; 2008; 37(1):72-5. PubMed ID: 18206530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
